| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,837,600 | 2,870,700 | 2,746,600 | 3,371,400 | | Cost of Revenue | (4,025,600) | 1,561,400 | 2,464,200 |
-
| | | Gross Profit | 6,863,200 | 1,309,300 | 282,400 | 3,371,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,568,400 | 911,200 |
-
| 2,923,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 294,800 | 398,100 | 282,400 | 448,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,200) | 18,700 | 5,400 | 8,800 | | Earnings Before Interest And Taxes | 299,800 | 403,600 | 287,800 | 457,200 | | Interest Expense | 33,800 | 27,400 | 26,800 | 32,700 | | Income Before Tax | 266,000 | 376,200 | 261,000 | 424,500 | | Income Tax Expense | 90,500 | 129,700 | 88,700 | 142,100 | | Minority Interest |
-
|
-
|
-
| (27,400) | | | | Net Income From Continuing Ops | 182,800 | 253,800 | 178,200 | 271,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 182,800 | 253,800 | 178,200 | 271,000 | | Preferred Stock And Other Adjustments | (17,200) | (20,400) | (13,700) |
-
| | | Net Income Applicable To Common Shares | $165,600 | $233,400 | $164,500 | $271,000 |
|
0.29% Nasdaq 
Income Statement
